Grifols

R&D

The importance of time: Grifols seeks biomarkers for early d...

Through a pioneering initiative called Chronos-PD, Grifols is partnering with the Michael J.

News

plasma test tubes being placed by a gloved hand in a lab

Grifols gets $21m award for Parkinson's biomarker hunt

Grifols has been awarded a $21m grant from the Michael J Fox Foundation to find plasma biomarkers to predict Parkinson's years before symptoms start.

News

Grifols files drug for rare bleeding disorder in the US

Grifols has filed for FDA approval of its new drug for bleeding disorder acquired fibrinogen deficiency (AFD), aiming for a first-in-class US launch.

News

Grifols slides as Brookfield pulls out of takeover talks

Brookfield has said it is withdrawing from negotiations to take over Grifols, sparking a slump in the Spanish pharma group's shares

News

Female scientist with pipette in laboratory

Grifols linked to €7bn takeover offer from Brookfield

Private equity company Brookfield has reportedly moved closer to taking control of Grifols, after months of disruption at the Spanish pharma company.

News

Grifols' executive chairman Thomas Glanzmann (l) and chief executive Nacho Abia (r)

Could Spain’s Grifols be heading for de-listing?

The family that owns Spanish drugmaker Grifols and private equity firm Brookfield are considering whether to take the company private in a deal that could be worth around €5.5 billion (almo

The importance of time: Grifols seeks biomarkers for early d...

Grifols gets $21m award for Parkinson's biomarker hunt

Grifols files drug for rare bleeding disorder in the US

Grifols slides as Brookfield pulls out of takeover talks

Grifols linked to €7bn takeover offer from Brookfield

Could Spain’s Grifols be heading for de-listing?

NHS "isn't delivering equitable care for rare diseases"

Using AI-driven synthetic personas to take your insights fur...

Grifols

Editor's Picks